$heff's $tation of $tocks & $olid DD

[read_this_n0w]

Celldex Announces Public Offering of Common Stock <CLDX.O>


http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20120223:nBw236682a

NEEDHAM, Mass.--(Business Wire)--
Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that it is offering
shares of its common stock in an underwritten public offering. All of the shares
in the offering will be sold by Celldex. The offering is subject to market
conditions, and there can be no assurance as to whether or when the offering may
be completed, or as to the actual size or terms of the offering. The shares will
be issued pursuant to a prospectus supplement filed as part of a shelf
registration statement previously filed with the Securities and Exchange
Commission (SEC) on Form S-3.

Jefferies & Company, Inc. is acting as the sole book-running manager for the
proposed offering. Wedbush PacGrow Life Sciences, Oppenheimer & Co. Inc., Brean
Murray, Carret & Co. and Roth Capital Partners, LLC are acting as co-managers
for the proposed offering.

A shelf registration statement relating to the shares was filed with the
Securities and Exchange Commission and is effective. A preliminary prospectus
supplement related to the offering will be filed with the SEC and will be
available on the SEC's website located at www.sec.gov. Copies of the preliminary
prospectus supplement and the accompanying prospectus relating to this offering
may be obtained from Jefferies & Company, Inc., Attention: Equity Syndicate
Prospectus Department, 520 Madison Avenue, 12th Floor, New York, NY, 10022, or
by telephone at 877-547-6340, or by email at
[e-mail].

This press release shall not constitute an offer to sell or the solicitation of
an offer to buy these securities, nor shall there be any sale of these
securities in any state or other jurisdiction in which such offer, solicitation
or sale would be unlawful prior to the registration or qualification under the
securities laws of any such state or other jurisdiction. Celldex intends to file
a preliminary prospectus supplement relating to the offering with the SEC, which
will be available along with the prospectus filed with the SEC in connection
with the shelf registration, on the SEC's website at www.sec.gov.